# EDGAR Filing Document

**Accession Number:** 0001760764
**File Stem:** 0001213900-23-023225
**Filing Date:** 2023-3
**Character Count:** 2589
**Document Hash:** 5ea6790be2febe6efc8d1d5ce2eaf25f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-023225.hdr.sgml**: 20230428

**ACCESSION NUMBER**: 0001213900-23-023225

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230327

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** G Medical Innovations Holdings Ltd.
- **CENTRAL INDEX KEY:** 0001760764
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 5 OPPENHEIMER ST.
- **CITY:** REHOVOT
- **STATE:** L3
- **ZIP:** 7670105
- **BUSINESS PHONE:** 972-89584777

**MAIL ADDRESS:**
- **STREET 1:** 5 OPPENHEIMER ST.
- **CITY:** REHOVOT
- **STATE:** L3
- **ZIP:** 7670105

**G Medical Innovations Holdings Ltd.**

**5 Oppenheimer St.**

**Rehovot, Israel 7670105**

March 27, 2023

*<u>VIA EDGAR</u>*

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: G Medical Innovations Holdings Ltd. (CIK: 0001760764) <br> <u>Registration Statement No. 333-269496 on Form F-1 (the "Registration Statement")</u>

Ladies and Gentlemen:

G Medical Innovations Holdings Ltd. (the "<u>Registrant</u>") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the "<u>Securities Act</u>"), so that it may become effective on March 29, 2023 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable. By separate letter, the underwriter of the issuance of the securities being registered has joined in this request for acceleration.

The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.

The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660-3092 and that such effectiveness also be confirmed in writing.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| G MEDICAL INNOVATIONS HOLDINGS LTD. | G MEDICAL INNOVATIONS HOLDINGS LTD. |
| By: | /s/ Dr. Yacov Geva |
|  | Dr. Yacov Geva |
|  | Chief Executive Officer |

---